Literature DB >> 786650

Tumour-associated antibodies against renal cell carcinomas detected by immunofluorescence.

R Ackermann.   

Abstract

Serum from 39 of 288 (13.5%) cancer patients contained antibodies detectable by immunofluorescence which reacted with frozen tumour sections from kidneys, prostate glands and ovaries. The serum did not react against areas of normal kidney taken from the same diseased organ. In comparison, 0.7% of normal persons and 3.8% of patients with non-malignant diseases had antibody activity. Sections from two colon carcinomas did not react with the serum. It is concluded that tumour-associated antibodies do not necessarily have histological type specificity and are worthy of further study.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 786650

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.

Authors:  A P van der Meijden; P A Steerenberg; I M van Hoogstraaten; J A Kerckhaert; L M Schreinemachers; E J Harthoorn-Lasthuizen; A M Hagenaars; W H de Jong; F M Debruijne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Quantitative measurements of humoral immune response in mice to a FANFT induced bladder tumor.

Authors:  U E Studer; J B deKernion; H Lovrekovich; L Lovrekovich
Journal:  Urol Res       Date:  1985

3.  Preliminary results on the use of the humoral immune response as a serum marker in patients with bladder tumors.

Authors:  U E Studer; J B deKernion; L Lovrekovich
Journal:  Urol Res       Date:  1985

4.  An investigation of cellular components released from human renal cancer and foetal kidney xenografts in nude mice (nu/nu) by cross-immunization of hairy littermate relatives.

Authors:  P N Matthews; J Hermon-Taylor; A G Grant
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.